Drug fends off kidney cancer progression
May 16, 2008 by admin · Leave a Comment
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. The study was led by Robert Motzer, MD, an attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), who will present the findings on May 31 at the annual meeting of the American Society for Clinical Oncology.
How less can be more when treating some kidney cancers
January 9, 2008 by admin · Leave a Comment
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact. The study will be published in the February issue of the Journal of Urology.
Experimental drug shows promise in advanced kidney cancer
September 26, 2007 by admin · Leave a Comment
Barcelona, Spain: A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.
The study, presented today (Wednesday) at the European Cancer Conference (ECCO 14) in Barcelona, showed that the experimental drug, axitinib, shrank tumours and delayed progression of the disease in a group of patients who are among the toughest to treat.
A Doctor and His Family, with 7 years of first-hand experience of life on dialysis
September 20, 2007 by admin · Leave a Comment
( Chicago ) According to the National Kidney Foundation, one out of every nine people in the United States is affected by kidney disease. DIALYSIS WITHOUT FEAR ( Oxford University Press, July 2007) is the first-ever family guide for dialysis patients who suffer from kidney/renal failure and who wish to simplify their lives and dispel the misconception that one must be tied down to their dialysis machine for the duration of their treatment, whether it be for a brief stint or for life.
What Is the Current Recommended Treatment for Lupus Nephritis?
August 1, 2007 by admin · Leave a Comment
Lupus nephritis is kidney disease that is caused by lupus. To start, it must be understood that there are many forms of kidney disease that are referred to as lupus nephritis. Each form is distinguished by characteristic patterns of abnormalities as defined by a kidney biopsy. (A biopsy is the removal of a sample of tissue for microscopic examination.) Typically, the findings on a kidney biopsy of a lupus patient are classified according to the appearance of the tissue and immune abnormalities seen under the microscope.
New Drug Combination Shrinks Kidney Cancers
May 31, 2006 by admin · Leave a Comment
DURHAM, N.C. — By using a new combination of two anticancer drugs, researchers at Duke University Medical Center have dramatically improved response rates of patients with metastatic kidney cancer, which is now generally considered incurable.
